title: Galanin message-associated peptide suppresses growth and the budded-to-hyphal-form transition of Candida albicans.
abstract: The expression of the mRNA encoding galanin message-associated peptide (GMAP) in human keratinocytes is upregulated by lipopolysaccharides and exposure to Candida albicans. GMAP has growth-inhibiting activity against C. albicans and inhibits the budded-to-hyphal-form transition, establishing GMAP as a possible new component of the innate immune system.
authors: Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Müllner Hauptstr. 48, A-5020 Salzburg, Austria.
authors: Isabella
authors: I
authors: Rauch
authors: Linda
authors: L
authors: Lundström
authors: Markus
authors: M
authors: Hell
authors: Wolfgang
authors: W
authors: Sperl
authors: Barbara
authors: B
authors: Kofler
mesh_terms: D000818:Animals; D001483:Base Sequence; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development; D002478:Cells, Cultured; D019004:Galanin / Q000235:genetics / Q000494:pharmacology* / Q000502:physiology; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012689:Sequence Homology, Nucleic Acid
chemical_list: D008070:Lipopolysaccharides; D012333:RNA, Messenger; C078371:galanin message-associated peptide; D019004:Galanin
references: FEBS Lett. 1983 Nov 28;164(1):124-8
references: 6197320
references: J Invest Dermatol. 2004 Apr;122(4):1050-3
references: 15102097
references: J Clin Invest. 1994 May;93(5):2258-62
references: 8182158
references: Biochem Biophys Res Commun. 1995 Feb 6;207(1):25-32
references: 7857273
references: J Exp Biol. 2004 Dec;207(Pt 25):4479-88
references: 15557033
references: Neuropeptides. 2004 Dec;38(6):331-43
references: 15567469
references: Nat Immunol. 2005 Jun;6(6):558-64
references: 15908937
references: J Invest Dermatol. 2005 Jun;124(6):1225-33
references: 15955098
references: Cell Microbiol. 2005 Nov;7(11):1546-54
references: 16207242
references: Crit Care Clin. 2006 Apr;22(2):291-311, vii
references: 16678001
references: Pharmacotherapy. 2006 Jun;26(6 Pt 2):68S-75S
references: 16716125
references: Curr Opin Pharmacol. 2006 Oct;6(5):468-72
references: 16890021
references: Curr Opin Drug Discov Devel. 2006 Sep;9(5):560-70
references: 17002216
references: J Leukoc Biol. 2000 Feb;67(2):233-9
references: 10670585
references: Respir Res. 2000;1(3):141-50
references: 11667978
references: Curr Drug Targets CNS Neurol Disord. 2002 Dec;1(6):531-41
references: 12769595
references: J Immunol. 1989 Dec 1;143(11):3703-7
references: 2584715